Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]
Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]
Thota Kanishka Rao, Amity University Kolkata Coronavirus became a household name, as the pandemic swept people off their feet, locking them in their houses, rendering them sick, leading to death on severe occasions. After months into the pandemic, in December 2020, the government of Israel approved the BNT162b2 COVID-19 vaccination and proclaimed a mass immunization […]
